Clinical Trials · NCT06565611
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Palatin Technologies, Inc
- Enrollment
- 108
- Start date
- Aug 2024
- Locations
- 4 sites, United States
- Primary endpoint
- Percent change in body weight between treatment arms